FundedIQ
Health Care

Vivent: Funding, Investors & Team (Oct 2026)

Vivent provides growers, breeders and agrochem companies with actionable information direct from plants themselves. We help clients see how and when plants respond to changing conditions and we provide early warning (days before visual symptoms) of abiotic and biotic stressors. With better information on plant responses, growers optimise conditions and have increased yields and fruit quality. Early warning enables more effective and environmentally preferable crop protection. Plant scientists accelerate agrochem product development and improve use recommendations. Breeders can identify beneficial traits in real-time.

vivent.ch LinkedIn Gland, Switzerland 11-50 employees
Health Care Medical Medical Device B2B
Total raised
$8.7M
Rounds
1
Latest
Undisclosed round
Nov 2025

Vivent has raised $8.7M across 1 funding round on record, the most recent an undisclosed round of $8.7M announced in Nov 2025.

That round is above the $4.8M median round size for Health Care companies tracked on FundedIQ over the last two years.

Vivent Company Profile and Key Stats

Total funding raised
$8.7M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$8.7M in Nov 2025
Employees
11-50
reported band
Headquarters
Gland, Switzerland

Latest funding round on record: Nov 2025.

Vivent Funding Rounds

Date
Round
Amount
Undisclosed round
$8.7M

Vivent Founders and Leadership Team

Name
Role
Contact
Nigel Wallbridge
Founder
—

No contact details are on record for this team yet.

Vivent Funding Compared to Other Health Care Startups

Segment
Companies
Median round
3,657
$4.8M
893
$3.8M

Vivent's latest round of $8.7M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Vivent in Health Care and Gland

Companies Similar to Vivent

MoleSense is to provide a wearable skin sensor to help monitor high-risk pregnancies.

Undisclosed round $110k

CeQur Simplicity helps people with diabetes by developing drug-delivery devices. They develop bolus insulin…

Series E $100M

Calmea develops advanced contactless sensing systems that invisibly track sleep and automatically modify…

Undisclosed round $190k

NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for…

Series B $33.6M

UNBOOUND is a medtech company and university spin-off (The Rockefeller University and University of Geneva)…

Undisclosed round $130k

Christina Vallgren and Marcus Palm, two physicists from CERN, co-founded Terapet along with Professor Raymond…

Undisclosed round $2.6M
Seed —

Axmed is a company that specializes in serving low and middle-income countries (LMICs), with the goal of…

Undisclosed round $6.0M

Babylat is an enricher device is the first automated, small-scale tabletop device for the protein enrichment…

Undisclosed round $1.0M

Altiscreen is creating and producing cutting-edge, portable drug-of-abuse detection systems. With the use of…

Undisclosed round $150k

Multiwave develops breakthrough Magnetic Resonance Imaging and Positron Emission Tomography devices. Founded…

Undisclosed round $4.5M

Qumea provides a unique solution for discreet patient monitoring. By fusing AI and 3D radar technology, QUMEA…

Undisclosed round —

Vivent Funding FAQs

What does Vivent do?

Vivent provides growers, breeders and agrochem companies with actionable information direct from plants themselves. We help clients see how and when plants respond to changing conditions and we provide early warning (days before visual symptoms) of abiotic and biotic stressors. With better information on plant responses, growers optimise conditions and have increased yields and fruit quality. Early warning enables more effective and environmentally preferable crop protection. Plant scientists accelerate agrochem product development and improve use recommendations. Breeders can identify beneficial traits in real-time.

How much funding has Vivent raised?

Vivent has raised $8.7M across 1 round on record. The most recent is an undisclosed round of $8.7M announced in Nov 2025.

When did Vivent last raise funding?

Vivent's most recent funding round on record is an undisclosed round of $8.7M, announced in Nov 2025.

Who founded Vivent?

FundedIQ lists Nigel Wallbridge (Founder) at Vivent.

Where is Vivent headquartered?

Vivent is based in Gland, Vaud, Switzerland.

How many employees does Vivent have?

Vivent is in the 11-50 employee band.

How does Vivent's funding compare to other Health Care startups?

Vivent's latest round of $8.7M is above the $4.8M median round size for Health Care companies on FundedIQ across 3,657 tracked companies over the last two years.

About FundedIQ's Vivent Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Vivent is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.